NEO
Price
$10.12
Change
+$0.21 (+2.12%)
Updated
Apr 24, 02:40 PM (EDT)
Capitalization
2.01B
5 days until earnings call
NVCR
Price
$17.80
Change
+$0.04 (+0.23%)
Updated
Apr 24, 02:41 PM (EDT)
Capitalization
1.66B
Earnings call today
Ad is loading...

NEO vs NVCR

Header iconNEO vs NVCR Comparison
Open Charts NEO vs NVCRBanner chart's image
NeoGenomics
Price$10.12
Change+$0.21 (+2.12%)
Volume$6.02K
Capitalization2.01B
NovoCure
Price$17.80
Change+$0.04 (+0.23%)
Volume$100
Capitalization1.66B
NEO vs NVCR Comparison Chart
Loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEO vs. NVCR commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a Buy and NVCR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (NEO: $9.89 vs. NVCR: $17.77)
Brand notoriety: NEO and NVCR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEO: 76% vs. NVCR: 123%
Market capitalization -- NEO: $2.01B vs. NVCR: $1.66B
NEO [@Medical Specialties] is valued at $2.01B. NVCR’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 0 FA rating(s) are green whileNVCR’s FA Score has 1 green FA rating(s).

  • NEO’s FA Score: 0 green, 5 red.
  • NVCR’s FA Score: 1 green, 4 red.
According to our system of comparison, NVCR is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 5 TA indicator(s) are bullish while NVCR’s TA Score has 5 bullish TA indicator(s).

  • NEO’s TA Score: 5 bullish, 3 bearish.
  • NVCR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, NEO is a better buy in the short-term than NVCR.

Price Growth

NEO (@Medical Specialties) experienced а +3.45% price change this week, while NVCR (@Medical Specialties) price change was +12.26% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.43%. For the same industry, the average monthly price growth was -7.35%, and the average quarterly price growth was -3.23%.

Reported Earning Dates

NEO is expected to report earnings on Jul 30, 2025.

NVCR is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Medical Specialties (+3.43% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEO($2.01B) has a higher market cap than NVCR($1.66B). NEO (-39.988) and NVCR (-40.369) have similar YTD gains . NEO has higher annual earnings (EBITDA): -17.61M vs. NVCR (-177.45M). NVCR has more cash in the bank: 911M vs. NEO (415M). NVCR (596M) and NEO (612M) have identical debt. NEO has higher revenues than NVCR: NEO (592M) vs NVCR (509M).
NEONVCRNEO / NVCR
Capitalization2.01B1.66B121%
EBITDA-17.61M-177.45M10%
Gain YTD-39.988-40.36999%
P/E Ratio49.50N/A-
Revenue592M509M116%
Total Cash415M911M46%
Total Debt612M596M103%
FUNDAMENTALS RATINGS
NEO vs NVCR: Fundamental Ratings
NEO
NVCR
OUTLOOK RATING
1..100
2716
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9194
PRICE GROWTH RATING
1..100
8062
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (73) in the Medical Or Nursing Services industry is in the same range as NVCR (100) in the Medical Specialties industry. This means that NEO’s stock grew similarly to NVCR’s over the last 12 months.

NEO's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as NVCR (100) in the Medical Specialties industry. This means that NEO’s stock grew similarly to NVCR’s over the last 12 months.

NEO's SMR Rating (91) in the Medical Or Nursing Services industry is in the same range as NVCR (94) in the Medical Specialties industry. This means that NEO’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's Price Growth Rating (62) in the Medical Specialties industry is in the same range as NEO (80) in the Medical Or Nursing Services industry. This means that NVCR’s stock grew similarly to NEO’s over the last 12 months.

NVCR's P/E Growth Rating (6) in the Medical Specialties industry is significantly better than the same rating for NEO (100) in the Medical Or Nursing Services industry. This means that NVCR’s stock grew significantly faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEONVCR
RSI
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
58%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 24 days ago
81%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSMMX18.04N/A
N/A
Invesco Summit C
MFECX107.70N/A
N/A
MFS Growth C
LYRIX24.36N/A
N/A
Lyrical US Value Equity Institutional
LSCNX19.44N/A
N/A
Loomis Sayles Small Cap Value N
LFGIX30.92N/A
N/A
Lord Abbett Focused Growth I

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with RGEN. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
+1.44%
RGEN - NEO
47%
Loosely correlated
+1.78%
FLGT - NEO
45%
Loosely correlated
+2.49%
QTRX - NEO
44%
Loosely correlated
+3.39%
RDNT - NEO
43%
Loosely correlated
+1.74%
ALGN - NEO
42%
Loosely correlated
+1.93%
More

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with RVTY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
+7.63%
RVTY - NVCR
36%
Loosely correlated
+1.46%
NEO - NVCR
36%
Loosely correlated
+1.44%
BLFS - NVCR
36%
Loosely correlated
+11.19%
TWST - NVCR
36%
Loosely correlated
+1.84%
FLGT - NVCR
36%
Loosely correlated
+2.49%
More